☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
us
A Peek into the US Healthcare System
May 7, 2024
Abbott Receives the US FDA’s Clearance for Alinity H-Series Hematology System
August 8, 2023
Insights+: The US FDA New Drug Approvals in February 2023
March 15, 2023
The US FDA Launches 5-Year Action Plan for Neurodegenerative Disease
June 27, 2022
The US FDA Extends Review Period of Myfembree’s sNDA to Treat Moderate to Severe Pain Associated with Endometriosis
May 9, 2022
The US FDA Issued Complete Response Letter to Hutchmed’s Surufatinib for the Treatment of Advanced Neuroendocrine Tumors
May 4, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.